Targeting virus-STAT interactions to generate novel attenuated ‘live’ vaccines (#169)
Gregory W Moseley
1
,
Alamgir Hossain
2
,
Florence Larrous
3
,
Stephen Rawlinson
1
,
Jinyu Zhan
2
,
Asish Sethi
2
,
Youssef Ibrahim
2
,
Maria Aloi
1
,
Kim G Lieu
2
,
Yee-Foong Mok
2
,
Michael Griffin
2
,
Toyoyuki Ose
4
,
Herve Bourhy
3
,
Naoto Ito
5
,
Paul R Gooley
2
- Department of Microbiology, Monash University, Clayton, VIC, Australia
- Dept. of Biochemistry and Molecular Biology, Bio21 Institute, University of Melbourne, Parkville, VIC, Australia
- Unit Lyssavirus Dynamics and Host Adaptation, Pasteur Institute, Paris, France
- Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
- Laboratory of Zoonotic Diseases, Gifu University, Gifu, Japan
Publish consent withheld
- (1) PLOS Pathogens. 2022. 18(5): e1010533. https://doi.org/10.1371/journal.ppat.1010533
(2) PLOS Pathogens. 2021. 17(7): e1009729. https://doi.org/10.1371/journal.ppat.1009729
(3) PLOS Pathogens. 2021. 17(6): e1009636. https://doi.org/10.1371/journal.ppat.1009636
(4) PLOS Pathogens. 2020. 16(9):e1008767. doi.org/10.1371/journal.ppat.1008767
(5) Cell Reports 2019. 29: 1934-1945
(6) PCT/AU2019/050908 "Novel Viruses" (filed 27/8/2019)